integration — 17 things I got wrong before I got it right
integration — 17 things I got wrong before I got it right. Making the case below, and I expect to lose some of it in the comments.
Sent the same vial to PeptideMeter and Medutest. 98.8% against a claimed 98.0%. The difference was the gradient, not the material.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
Did you run a blank between injections?
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
Trace posted without axis labels — asked for a relabelled version rather than removing it.
report the method or do not report the number
[removed by moderator]
Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
214nm sees the peptide bond, 280nm sees the aromatics
Why two honest labs report different numbers on the same vial.
Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.
Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.
A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
A shoulder that does not baseline-resolve cannot be quantified honestly.
This is the whole methodological point of the board in one line.
That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.
- 1report the method or do not report the number6 comments in this branch · started by u/hana_lehtinen